Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.
Financial Results:
Sanofi India Ltd reported Revenues for Q3FY24 of ₹694.00 Crores up from ₹672.00 Crore year on year, a rise of 3.27%.
Total Expenses for Q3FY24 of ₹516.00 Crores up from ₹515.00 Crores year on year, a rise of 0.19%.
Consolidated Net Profit of ₹138.00 Crores up 5.34% from ₹131.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹59.79, up 5.19% from ₹56.84 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.